27013966|t|Molecular Mechanisms Regulating LPS-Induced Inflammation in the Brain.
27013966|a|Neuro-inflammation, one of the pathogenic causes of neurodegenerative diseases, is regulated through the cholinergic anti-inflammatory pathway via the alpha7 nicotinic acetylcholine receptor (alpha7 nAChR). We previously showed that either bacterial lipopolysaccharide (LPS) or immunization with the alpha7(1-208) nAChR fragment decrease alpha7 nAChRs density in the mouse brain, exacerbating chronic inflammation, beta-amyloid accumulation and episodic memory decline, which mimic the early stages of Alzheimer's disease (AD). To study the molecular mechanisms underlying the LPS and antibody effects in the brain, we employed an in vivo model of acute LPS-induced inflammation and an in vitro model of cultured glioblastoma U373 cells. Here, we report that LPS challenge decreased the levels of alpha7 nAChR RNA and protein and of acetylcholinesterase (AChE) RNA and activity in distinct mouse brain regions, sensitized brain mitochondria to the apoptogenic effect of Ca(2+) and modified brain microRNA profiles, including the cholinergic-regulatory CholinomiRs-132/212, in favor of anti-inflammatory and pro-apoptotic ones. Adding alpha7(1-208)-specific antibodies to the LPS challenge prevented elevation of both the anti-inflammatory and pro-apoptotic miRNAs while supporting the resistance of brain mitochondria to Ca(2+) and maintaining alpha7 nAChR/AChE decreases. In U373 cells, alpha7-specific antibodies and LPS both stimulated interleukin-6 production through the p38/Src-dependent pathway. Our findings demonstrate that acute LPS-induced inflammation induces the cholinergic anti-inflammatory pathway in the brain, that alpha7 nAChR down-regulation limits this pathway, and that alpha7-specific antibodies aggravate neuroinflammation by inducing the pro-inflammatory interleukin-6 and dampening anti-inflammatory miRNAs; however, these antibodies may protect brain mitochondria and decrease the levels of pro-apoptotic miRNAs, preventing LPS-induced neurodegeneration. 
27013966	32	35	LPS	Chemical	MESH:D008070
27013966	44	56	Inflammation	Disease	MESH:D007249
27013966	71	89	Neuro-inflammation	Disease	MESH:D007249
27013966	123	149	neurodegenerative diseases	Disease	MESH:D019636
27013966	193	205	inflammatory	Disease	MESH:D007249
27013966	263	275	alpha7 nAChR	Gene	11441
27013966	321	339	lipopolysaccharide	Chemical	MESH:D008070
27013966	341	344	LPS	Chemical	MESH:D008070
27013966	371	390	alpha7(1-208) nAChR	Gene	16404
27013966	438	443	mouse	Species	10090
27013966	472	484	inflammation	Disease	MESH:D007249
27013966	516	539	episodic memory decline	Disease	MESH:D060825
27013966	573	592	Alzheimer's disease	Disease	MESH:D000544
27013966	594	596	AD	Disease	MESH:D000544
27013966	648	651	LPS	Chemical	MESH:D008070
27013966	725	728	LPS	Chemical	MESH:D008070
27013966	737	749	inflammation	Disease	MESH:D007249
27013966	784	796	glioblastoma	Disease	MESH:D005909
27013966	797	801	U373	CellLine	CVCL:2818
27013966	830	833	LPS	Chemical	MESH:D008070
27013966	868	880	alpha7 nAChR	Gene	11441
27013966	904	924	acetylcholinesterase	Gene	11423
27013966	926	930	AChE	Gene	11423
27013966	961	966	mouse	Species	10090
27013966	1041	1047	Ca(2+)	Chemical	-
27013966	1161	1173	inflammatory	Disease	MESH:D007249
27013966	1205	1218	alpha7(1-208)	Gene	16404
27013966	1246	1249	LPS	Chemical	MESH:D008070
27013966	1297	1309	inflammatory	Disease	MESH:D007249
27013966	1392	1398	Ca(2+)	Chemical	-
27013966	1428	1432	AChE	Gene	43
27013966	1447	1451	U373	CellLine	CVCL:2818
27013966	1459	1465	alpha7	Gene	28885
27013966	1490	1493	LPS	Chemical	MESH:D008070
27013966	1510	1523	interleukin-6	Gene	3569
27013966	1547	1550	p38	Gene	1432
27013966	1551	1554	Src	Gene	6714
27013966	1610	1613	LPS	Chemical	MESH:D008070
27013966	1622	1634	inflammation	Disease	MESH:D007249
27013966	1664	1676	inflammatory	Disease	MESH:D007249
27013966	1704	1716	alpha7 nAChR	Gene	11441
27013966	1763	1769	alpha7	Gene	16404
27013966	1800	1817	neuroinflammation	Disease	MESH:D000090862
27013966	1838	1850	inflammatory	Disease	MESH:D007249
27013966	1851	1864	interleukin-6	Gene	16193
27013966	1884	1896	inflammatory	Disease	MESH:D007249
27013966	2022	2025	LPS	Chemical	MESH:D008070
27013966	2034	2051	neurodegeneration	Disease	MESH:D019636
27013966	Association	MESH:D019636	11441
27013966	Positive_Correlation	16193	16404
27013966	Association	MESH:D060825	16404
27013966	Association	16404	43
27013966	Association	MESH:D007249	28885
27013966	Positive_Correlation	MESH:D008070	MESH:D019636
27013966	Positive_Correlation	MESH:D008070	MESH:D007249
27013966	Positive_Correlation	MESH:D008070	MESH:D000544
27013966	Association	MESH:D007249	11423
27013966	Association	MESH:D007249	16404
27013966	Positive_Correlation	MESH:D008070	MESH:D060825
27013966	Association	MESH:D007249	11441
27013966	Association	MESH:D000544	16404
27013966	Association	1432	3569
27013966	Negative_Correlation	MESH:D008070	11441
27013966	Association	1432	28885
27013966	Positive_Correlation	MESH:D008070	3569
27013966	Positive_Correlation	28885	3569
27013966	Association	28885	6714
27013966	Negative_Correlation	MESH:D008070	11423
27013966	Association	MESH:D000090862	16404
27013966	Association	MESH:D008070	1432

